Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of a Breath Test Using Volatile Organic Markers for Monitoring Cirrhosis and Detecting Primary Liver Tumours (VOCAL2)

NCT06864195 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT06864195
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06864195 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of a Breath Test Using Volatile Organic Markers for Monitoring Cirrhosis and Detecting Primary Liver Tumours (VOCAL2)
Lead sponsor
Imperial College London
Phase
Observational
Overall status
Recruiting
Start date
February 13, 2025
Completion date
February 28, 2027
Enrollment
750 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cholangiocarcinoma, cholangitis, sclerosing, hepatocellular carcinoma (hcc), liver cirrhosis